Vitamin D and multiple sclerosis: what is the clinical impact?

摘要: Evidence for a causal role vitamin D in multiple sclerosis (MS) is being gathered. Epidemiological, molecular and animal model studies have paved the way our understanding of effects demyelinating disease. Several clinical trials been completed more are under to understand full extent value supplementation on disease progression. Many questions remain unanswered however careful study design increasingly pertinent. Timing exposure, dosage transgenerational some several important that need be addressed. In this issue, Carlson Rose highlight these points provide review MS with an emphasis most recent studies. Further evidence deficiency as factor, its targets prospect therapeutic preventative agent warrant further study.